Related Experiment Video
Updated: Jan 28, 2026

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat
Published on: June 4, 2012
Antimicrobial management of Tropheryma whipplei endocarditis: the Spanish Collaboration on Endocarditis (GAMES)
Lara García-Álvarez1, M Mercedes Sanz1, Mercedes Marín2
1Departamento de Enfermedades Infecciosas, Hospital Universitario San Pedro-Centro de investigación Biomédica de La Rioja (CIBIR), Logroño, Spain.
Objectives:
Tropheryma whipplei has been detected in 3.5% of the blood culture-negative cases of endocarditis in Spain. Experience in the management of T. whipplei endocarditis is limited. Here we report the long-term outcome of the treatment of previously reported patients who were diagnosed with infective endocarditis (IE) caused by T. whipplei from the Spanish Collaboration on Endocarditis-Grupo de Apoyo al Manejo de la Endocarditis Infecciosa en España (GAMES) and discuss potential options for antimicrobial therapy for IE caused by T. whipplei.
Patients And Methods:
Seventeen patients with T. whipplei endocarditis were recruited between 2008 and 2014 in 25 Spanish hospitals. Patients were classified according to the therapeutic regimen: ceftriaxone and trimethoprim/sulfamethoxazole, doxycycline + hydroxychloroquine and other treatment options.
Results:
Follow-up data were obtained from 14 patients. The median follow-up was 46.5 months. All patients completed the antibiotic treatment prescribed, with a median duration of 13 months. Six patients were treated with ceftriaxone and trimethoprim/sulfamethoxazole (median duration 13 months), four with doxycycline + hydroxychloroquine (median duration 13.8 months) and four with other treatment options (median duration 22.3 months). The follow-up after the end of the treatments was between 5 and 84 months (median 24 months).
Conclusions:
All treatment lines were effective and well tolerated. Therapeutic failures were not detected during the treatment. None of the patients died or experienced a relapse during the follow-up. Only six patients received antibiotic treatment in accordance with guidelines. These data suggest that shorter antimicrobial treatments could be effective.
Insights
Tropheryma whipplei endocarditis treatment showed effective and well-tolerated outcomes in Spanish patients. Shorter antimicrobial regimens may be sufficient, as no relapses or deaths occurred during long-term follow-up.
Area of Science:
- Infectious Diseases
- Cardiology
- Microbiology
Background:
- Tropheryma whipplei is a rare cause of infective endocarditis (IE), particularly in blood culture-negative cases.
- Experience with T. whipplei endocarditis management is limited, necessitating further research into effective treatment strategies.
Purpose of the Study:
- To evaluate the long-term outcomes of Tropheryma whipplei endocarditis treatment in Spanish patients.
- To discuss potential antimicrobial therapy options for T. whipplei IE.
Main Methods:
- A cohort of 17 patients with T. whipplei endocarditis was recruited across 25 Spanish hospitals between 2008 and 2014.
- Patients received various treatment regimens, including ceftriaxone and trimethoprim/sulfamethoxazole, or doxycycline plus hydroxychloroquine.
- Long-term follow-up data were collected for 14 patients, with a median follow-up of 46.5 months.
Main Results:
- All treatment regimens were effective and well-tolerated, with no therapeutic failures during treatment.
- No deaths or relapses were observed during the median 24-month follow-up period after treatment completion.
- The median antibiotic treatment duration was 13 months, with some patients receiving longer courses.
Conclusions:
- Tropheryma whipplei endocarditis can be effectively treated with various antimicrobial regimens.
- Current data suggest that shorter antimicrobial treatments might be sufficient for T. whipplei IE.
- Further research is warranted to establish optimal treatment durations and confirm the efficacy of shorter regimens.
Related Concept Videos
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis I: Introduction
Antimicrobial Effectiveness
Chronic Pancreatitis II: Collaborative Care
Assessment:

